close

Amid concerns over effectiveness, govt ramping up Remdesivir production

Remdesivir may soon be dropped from ICMR's Covid treatment protocol, as experts have questioned its effectiveness in Covid treatment.

Remdesivir
Premium

A man holds boxes of Remdesivir, an antiviral drug used to treat Covid-19 coronavirus symptoms, purchased from a government dispensary, in Chennai (Photo: PTI)

The Indian government, on Wednesday, claimed it has ramped up the production of Remdesivir, an anti-viral drug prescribed for treating moderate-to-critical Covid patients, by 10 times. From 1 million vials

Also Read

Bharat Biotech's Covaxin effective against Covid-19 UK strain: ICMR

Covaxin neutralises the double-mutant coronavirus strain, says ICMR

Covaxin's efficacy shows immense strength of Atmanirbhar Bharat: ICMR chief

From crunch time to a bigger bite, Apple's India biz makes a turnaround

How closing schools for another year may set India back a few years

Scientists agree Covid is airborne, want overhaul of ventilation systems

Should my child get coronavirus vaccine? 7 questions answered by an expert

Huge public-pvt effort needed to boost health if there's third Covid wave

'INNergise' to Mood Diet: Five-star hotels go all out to beat Covid blues

What is mucormycosis, the deadly fungal infection among Covid patients

First Published: May 19 2021 | 4:53 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com